SPDR S&P Biotech ETF
XBI
#260
ETF rank
€9.80 B
Marketcap
🇺🇸 US
Market
140,96 €
Share price
-0.35%
Change (1 day)
73.00%
Change (1 year)
Categories

Expense ratio and fees for SPDR S&P Biotech ETF (XBI)

Expense Ratio

Expense Ratio as of May 2025: 0.35%

Gross Expense Ratio

Gross Expense Ratio as of September 2026: 0.35%